antibody-drug conjugates

Lonza to expand ADC capacity, broaden collab with US drugmaker

Lonza said that it will expand its capacity to produce ADC drugs. The CDMO also has increased the scope of its partnership with an unnamed U.S. drugmaker

Kevin Dunleavy Jul 1, 2026 3:22pm

Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC

Jun 24, 2026 5:00pm

ADC plots 17% staff cuts amid Zynlonta safety concerns

Jun 24, 2026 10:19am

Gilead's Trodelvy stumbles in first-line NSCLC

Jun 9, 2026 11:14am

Patient deaths raise questions about ADC's cancer drug Zynlonta

Jun 4, 2026 11:38am

At ASCO, China biotech industry cements its coming of age

Jun 3, 2026 8:50am